Providing support and services for people and families living with ALS in Ontario.
Funding high-quality research that offers the most promise to slow down ALS or even stop it.
Advocating for policy that will have a meaningful impact on people living with ALS today and in the future.
Many individuals and organizations generously give their time to create and host fundraising even...
Eight projects receive funding to find answers and fuel discoveries in ALS research Toronto – In their effort to fund progress and innovation in amyotrophic lateral sclerosis (ALS) research, the ALS Society of Canada (ALS Canada) and Brain Canada are...
March 8, 2024 - Amylyx Pharmaceuticals has announced that the PHOENIX Phase 3 clinical trial of AMX0035 did not meet its primary or secondary endpoints. The results from the 48-week...
Read the update